32. Hansen P, Kovanen V, Holmich P, et al. Micromechanical properties and collagen composition of ruptured human achilles tendon. Am J Sports Med 2013;41:437-43. 33. Maffulli N, Ewen SW, Waterston SW, Reaper J, Barrass V. Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons. An in vitro model of human tendon healing. AM J SPORTS MED 2000;28:499-505. 34. Jarvinen TAH, Jarvinen TLN, Kannus P, Jozsa L, Jarvinen M. Collagen fibres of the spontaneously ruptured human tendons display decreased thickness and crimp angle. J Orthop Res 2004;22:1303-9. 35. Bleakney RR, Tallon C, Wong JK, Lim KP, Maffulli N. Long-term ultrasonographic features of the Achilles tendon after rupture. CLIN J SPORT MED 2002;12:273-8. 36. Maffulli N, Barrass V, Ewen SW. Light microscopic histology of achilles tendon ruptures. A comparison with unruptured tendons. Am J Sports Med 2000;28:857-63. 37. Leppilahti J, Korpelainen R, Karpakka J, Kvist M, Orava S. Ruptures of the Achilles tendon: relationship to inequality in length of legs and to patterns in the foot and ankle. FOOT ANKLE INT 1998;19:683-7. 38. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 2006;54:832-42. 39. Posthumus M, September AV, Schwellnus MP, Collins M. Investigation of the Sp1-binding site polymorphism within the COL1A1 gene in participants with Achilles tendon injuries and controls. Journal of Science and Medicine in Sport 2009;12:184-9. 40. Petersen W, Pufe T, Zantop T, Tillmann B, Tsokos M, Mentlein R. Expression of VEGFR-1 and VEGFR-2 in Degenerative Achilles Tendons. Clin Orthop Relat Res 2004:286-91. 41. Legerlotz K, Jones ER, Screen HR, Riley GP. Increased expression of IL-6 family members in tendon pathology. Rheumatology (OxFord) 2012;51:1161-5. 42. Kujala UM, Jarvinen M, Natri A, et al. ABO blood groups and musculoskeletal injuries. INJURY 1992;23:131-3. 43. Maffulli N, Reaper JA, Waterston SW, Ahya T. ABO blood groups and achilles tendon rupture in the Grampian Region of Scotland. Clin J Sport Med 2000;10:269-71. 44. Raunest J, Burrig KF, Derra E. Pathogenesis of Achilles tendon rupture. Chirurg 1990;61:815-9. 45. Kujala UM, Sarna S, Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. CLIN J SPORT MED 2005;15:133-5. 46. Corrao G, Zambon A, Bertu L, et al. Evidence of tendinitis provoked by fluoroquinolone treatment a case-control study. Drug Saf 2006;29:889-96. 47. Sode J, Obel N, Hallas J, Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: A population-based cohort study. Eur J Clin Pharmacol 2007;63:499-503. 48. Longo UG, Ronga M, Maffulli N. Acute ruptures of the achilles tendon. Sports Med Arthrosc 2009;17:127-38. 49. Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother 2000;44:261-6. 50. Jorgensen C, Anaya JM, Didry C, et al. [Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case] Arthropathies et tendinopathie achilleenne induites par la pefloxacine. A propos d’une observation. Rev Rhum Mal Osteoartic 1991;58:623-5. 51. Movin T, Gad A, Guntner P, Foldhazy Z, rolf C. Pathology of the achilles tendon in association with ciprofloxacin treatment. FOOT ANKLE INT 1997;18:297-9. 52. Jarvinen TA, Kannus P, Paavola M, Jarvinen TL, Jozsa L, Jarvinen M. Achilles tendon injuries. Curr Opin Rheumatol 2001;13:150-5. 53. Jones JG. Achilles tendon rupture following steroid injection. J Bone Joint Surg Am 1985;67:170. 54. Smith M, Simpson NE. Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogenet Cell Genet 1989;51:202-25. 55. Samiric T, Ilic MZ, Handley CJ. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 2004;23:127-40. 56. Corps AN, Robinson AH, Movin T, et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology (OxFord) 2004;43:969-72. 57. Scott A, Lian O, Bahr R, Hart DA, Duronio V. VEGF expression in patellar tendinopathy: a preliminary study. Clin Orthop Relat Res 2008;466:1598-604. 58. Wang JH, Jia F, Yang G, et al. Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res 2003;44:128-33. 59. Hui W, Bell M, Carroll G. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants. Cytokine 1996;8:495-500. Over de auteurs Femke M. Claessen MD1 Robert- Jan de Vos MD, PhD1,2 Max Reijman PhD1 Duncan E. Meuffels MD, PhD1 1. Orthopaedie, Erasmus MC, Rotterdam 2. Sportgeneeskunde, Sport Medisch Centrum Maasstad, Barendrecht Correspondentieadres Duncan E. Meuffels MD, PhD Orthopaedische chirurgie, Erasmus Medisch Centrum PO Box 2040 3000 CA Rotterdam Telefoonnummer: +31 10 7036106; Fax: +31 10 7031002; d.meuffels@erasmusmc.nl nummer 1 | maart 2015 | Sport & Geneeskunde 39 Pagina 38
Pagina 40Scoor meer met een webwinkel in uw folders. Velen gingen u voor en publiceerden studiegidsen online.
Sport & Geneeskunde nummer 1 | maart 2015 Lees publicatie 45Home